4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001104659-22-092992
Director bought 425,531 shares at $23.50 ($9,999,979)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC Director | 2022-08-17 | Purchase | +425,531 | $23.50 | $9,999,979 | 1,363,764 | I: show line 1 in the form |
| Open-market purchases · 425,531 sh · avg $23.50 · $9,999,979 | |||||||
Loading xslF345X03/tm2224209-1_4seq1.xml…